Informa plc (LON:INF - Get Free Report)'s share price reached a new 52-week high on Wednesday . The company traded as high as GBX 946.20 ($12.65) and last traded at GBX 945.60 ($12.64), with a volume of 2409210 shares traded. The stock had previously closed at GBX 940.20 ($12.57).
Wall Street Analyst Weigh In
Separately, JPMorgan Chase & Co. began coverage on Informa in a research report on Wednesday, September 3rd. They set an "overweight" rating and a GBX 1,020 price target for the company. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of GBX 975.
Check Out Our Latest Report on INF
Informa Trading Up 0.4%
The company has a debt-to-equity ratio of 31.98, a quick ratio of 1.70 and a current ratio of 0.56. The company has a 50 day moving average of GBX 902.84 and a two-hundred day moving average of GBX 828.23. The stock has a market cap of £12.14 billion, a PE ratio of 171.56, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12.
Informa (LON:INF - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported GBX 30.10 earnings per share for the quarter. Informa had a return on equity of 4.75% and a net margin of 9.30%. Sell-side analysts anticipate that Informa plc will post 59.3240265 earnings per share for the current fiscal year.
Insider Buying and Selling at Informa
In other news, insider Stephen A. Carter sold 406,936 shares of the business's stock in a transaction that occurred on Tuesday, July 29th. The stock was sold at an average price of GBX 865, for a total transaction of £3,519,996.40. 0.41% of the stock is currently owned by corporate insiders.
Informa Company Profile
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.